EWTX logo

Edgewise Therapeutics (EWTX)

Profile

Full Name

Edgewise Therapeutics, Inc.

Ticker Symbol

EWTX

Exchange

NASDAQ

Country

United States

IPO

March 26, 2021

Indexes

Not included

Employees

110

Key Details

Price

$12.84(-1.38%)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.45(+7.64% YoY)

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 3, 25 Scotiabank
Sector Perform
Apr 3, 25 RBC Capital
Outperform
Apr 2, 25 Piper Sandler
Overweight
Mar 7, 25 Scotiabank
Sector Outperform
Mar 4, 25 RBC Capital
Outperform
Jan 22, 25 Stifel
Hold
Dec 17, 24 Evercore ISI Group
Outperform
Nov 27, 24 Truist Securities
Buy
Nov 22, 24 Evercore ISI Group
Outperform
Nov 8, 24 Wedbush
Outperform

Institutional Ownership

  • What is the ticker symbol for Edgewise Therapeutics?
  • Does Edgewise Therapeutics pay dividends?
  • What sector is Edgewise Therapeutics in?
  • What industry is Edgewise Therapeutics in?
  • What country is Edgewise Therapeutics based in?
  • When did Edgewise Therapeutics go public?
  • Is Edgewise Therapeutics in the S&P 500?
  • Is Edgewise Therapeutics in the NASDAQ 100?
  • Is Edgewise Therapeutics in the Dow Jones?
  • When was Edgewise Therapeutics's last earnings report?
  • When does Edgewise Therapeutics report earnings?
  • Should I buy Edgewise Therapeutics stock now?

What is the ticker symbol for Edgewise Therapeutics?

The ticker symbol for Edgewise Therapeutics is NASDAQ:EWTX

Does Edgewise Therapeutics pay dividends?

No, Edgewise Therapeutics does not pay dividends

What sector is Edgewise Therapeutics in?

Edgewise Therapeutics is in the Healthcare sector

What industry is Edgewise Therapeutics in?

Edgewise Therapeutics is in the Biotechnology industry

What country is Edgewise Therapeutics based in?

Edgewise Therapeutics is headquartered in United States

When did Edgewise Therapeutics go public?

Edgewise Therapeutics's initial public offering (IPO) was on March 26, 2021

Is Edgewise Therapeutics in the S&P 500?

No, Edgewise Therapeutics is not included in the S&P 500 index

Is Edgewise Therapeutics in the NASDAQ 100?

No, Edgewise Therapeutics is not included in the NASDAQ 100 index

Is Edgewise Therapeutics in the Dow Jones?

No, Edgewise Therapeutics is not included in the Dow Jones index

When was Edgewise Therapeutics's last earnings report?

Edgewise Therapeutics's most recent earnings report was on Mar 3, 2025

When does Edgewise Therapeutics report earnings?

The next expected earnings date for Edgewise Therapeutics is May 9, 2025

Should I buy Edgewise Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page